Participation of prostaglandin E2 and platelet-activating factor in thapsigargin-induced production of interleukin-6

European Journal of Pharmacology

Volumn 434, Issue 3, 2002, Pages 187-196

  Ichinowatari, Gaku ^a   Yamada, Masateru ^a   Yaginuma, Hiroshi ^a   Tsuyuki, Kousei ^a   Tanimoto, Atsuo ^a   Ohuchi, Kazuo ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Interleukin 6; Macrophage; PAF (platelet activating factor); Prostaglandin E2; SK F 98625; Thapsigargin

Indexed keywords

2,5 BIS(3,4,5 TRIMETHOXYPHENYL)TETRAHYDROFURAN; 6 (2 CHLOROPHENYL) 9 CYCLOPROPYLCARBONYL 7,8,9,10 TETRAHYDRO 1,4 DIMETHYL 4H PYRIDO[4',3'; 6 (2 CHLOROPHENYL) 9 CYCLOPROPYLCARBONYL 7,8,9,10 TETRAHYDRO 1,4 DIMETHYL 4H PYRIDO[4',3':4,5]THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE; ACYLTRANSFERASE INHIBITOR; DIETHYL 7 (3,4,5 TRIPHENYL 2 OXO 2,3 DIHYDROIMIDAZOL 1 YL)HEPTANE PHOSPHONATE; INTERLEUKIN 6; MESSENGER RNA; PROSTAGLANDIN E2; THAPSIGARGIN; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG; 2,5-BIS(3,4,5-TRIMETHOXYPHENYL)TETRAHYDROFURAN; ACYL CARRIER PROTEIN ACETYLTRANSFERASE; ACYLTRANSFERASE; AZEPINE DERIVATIVE; CELL SURFACE RECEPTOR; ENZYME INHIBITOR; FIBRINOGEN RECEPTOR; FURAN DERIVATIVE; G PROTEIN COUPLED RECEPTOR; IMIDAZOLE DERIVATIVE; INDOMETACIN; ORGANOPHOSPHORUS COMPOUND; SK&F 98625; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TRIAZOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; MALE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; GENETICS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACETYLTRANSFERASES; ACYL-CARRIER PROTEIN S-ACETYLTRANSFERASE; ANIMALS; AZEPINES; CELLS, CULTURED; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; FURANS; IMIDAZOLES; INDOMETHACIN; INTERLEUKIN-6; MACROPHAGES, PERITONEAL; MALE; ORGANOPHOSPHORUS COMPOUNDS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; THAPSIGARGIN; TRIAZOLES;

EID: 0037059325     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01547-3     Document Type: Article

References (48)

1. 2 enhances interleukin 8 (IL-8) and IL-6 but inhibits GMCSF production by IL-1 stimulated human synovial fibloblasts in vitro
2. IL-6-regulated transcription factors
3. Platelet-activating factor induces collagenase expression in corneal epithelial cells
4. Involvement of inflammatory mediators in macrophage antitumor activity
5. Thapsigargin and cyclopiazonic acid initiate rapid and dramatic increases of IL-6 mRNA expression and IL-6 secretion in murine peritoneal macrophages
6. Inhibitors of CoA-independent transacylase block the movement of arachidonate into 1-ether-linked phospholipids of human neutrophils
7. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
8. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators)
9. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogen
10. Purification and characterization of platelet-activating factor acetylhydrolase II from bovine liver cytosol
11. 2 in a murine model of inflammation: Possible role of cyclooxygenase-2
12. trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor
13. Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor alpha-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibloblasts
14. Platelet-activating factor induces NF-κB activation through a G protein-coupled pathway
15. Levels of circulating tumor necrosis factor α and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulfate
16. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex
17. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
18. Enhancement by staurosporine of platelet-activating factor formation in N-formyl peptide-challenged human neutrophils is mediated by intracellular platelet-activating factor binding sites
19. Sequential cytokine dynamics in chronic rejection of rat renal allografts: Roles for cytokines RANTES and MCP-1
20. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction
21. 2 production by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters in macrophages and its inhibition by cycloheximide
22. Stimulation of arachidonic acid metabolism in rat peritoneal macrophages by thapsigargin, a non-(12-O-tetradecanoylphorbol 13-acetate) (TPA)-type tumor promoter
23. Analysis of the stimulative effect of thapsigargin, a non-TPA-type tumour promoter, on arachidonic acid metabolism in rat peritoneal macrophages
24. Transcriptional regulation of neuromodulin (GAP-43) in mouse neuroblastoma clone N1E-115 as evaluated by the RT/PCR method
25. Effect of 17β-estradiol on secretion of platelet-activating factor acetylhydrolase by HepG2 cells
26. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages
27. Involvement of a NF-κB-like transcription factor in the activation of the inerleukin-6 gene by inflammatory lymphokines
28. Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages
29. Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes
30. An improved colorimetric assay for interleukin 2
31. Selective deacylation of arachidonate-containing ethanolamine-linked phosphoglycerides in stimulated human neutrophils
32. The calcium mobilizing tumor promoting agent, thapsigargin elevates the platelet cytoplasmic free calcium concentration to a higher steady state level. A possible mechanism of action for the tumor promotion
33. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist
34. A coenzyme A-independent transacylase is linked to the formation of platelet-activating factor (PAF) by generating the lyso-PAF intermediate in the remodeling pathway
35. Interleukin-6: An overview
36. Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop
37. 3H]-alkyl-2-arachidonyl-sn-glycero-3-phosphorylcholine to lyso platelet-activating factor by the CoA-independent transacylase in membrane fractions of human neutrophils
38. Preparation of immunoaffinity mini-columns for the analysis of platelet activating factor (PAF) in biological samples
39. Pharmacological analysis of neutrophil chemotactic factor production by leucocytes and roles of PAF in allergic inflammation in rats
40. Enhancement by cyclo-oxygenase inhibitors of platelet-activating factor production in thapsigargin-stimulated macrophages
41. Characterization of CoA-independent transacylase activity in U937 cells
42. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils
43. Effects of CoA-independent transacylase inhibitors on the production of lipid inflammatory mediators
44. 2
45. Inhibition of tumor necrosis factor-α production by SK&F 98625, a CoA-independent transacylase inhibitor, in cultured rat peritoneal macrophages
46. Possible participation of intracellular platelet-activating factor in tumor necrosis factor-α production by rat peritoneal macrophages
47. Inhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibloblasts by treatment with aurothioglucose
48. Modulation of the nuclear factor κB pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor